Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2007 2
2008 7
2009 12
2010 5
2011 3
2012 4
2013 3
2014 2
2015 2
2016 1
2019 1
2020 2
2021 1
2022 3
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer.
Hughes DJ, Josephides E, O'Shea R, Manickavasagar T, Horst C, Hunter S, Tanière P, Nonaka D, Van Hemelrijck M, Spicer J, Goh V, Bille A, Karapanagiotou E, Cook GJR. Hughes DJ, et al. Among authors: karapanagiotou e. Eur Radiol. 2024 Sep;34(9):5889-5902. doi: 10.1007/s00330-024-10651-5. Epub 2024 Feb 22. Eur Radiol. 2024. PMID: 38388716 Free PMC article.
Bevacizumab-induced hypertension: pathogenesis and management.
Syrigos KN, Karapanagiotou E, Boura P, Manegold C, Harrington K. Syrigos KN, et al. Among authors: karapanagiotou e. BioDrugs. 2011 Jun 1;25(3):159-69. doi: 10.2165/11590180-000000000-00000. BioDrugs. 2011. PMID: 21627340 Review.
Prostate cancer in the elderly.
Syrigos KN, Karapanagiotou E, Harrington KJ. Syrigos KN, et al. Among authors: karapanagiotou e. Anticancer Res. 2005 Nov-Dec;25(6C):4527-33. Anticancer Res. 2005. PMID: 16334137 Free article. Review.
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry.
Cortellini A, Brunetti L, Di Fazio GR, Garbo E, Pinato DJ, Naidoo J, Katz A, Loza M, Neal JW, Genova C, Gettinger S, Kim SY, Jayakrishnan R, El Zarif T, Russano M, Pecci F, Di Federico A, Awad M, Alessi JV, Montrone M, Owen DH, Signorelli D, Fidler MJ, Li M, Camerini A, De Giglio A, Young L, Vincenzi B, Metro G, Passiglia F, Yendamuri S, Guida A, Ghidini M, Awosika NO, Napolitano A, Fulgenzi CAM, Grisanti S, Grossi F, D'Incecco A, Josephides E, Van Hemelrijck M, Russo A, Gelibter A, Spinelli G, Verrico M, Tomasik B, Giusti R, Newsom-Davis T, Bria E, Sebastian M, Rost M, Forster M, Mukherjee U, Landi L, Mazzoni F, Aujayeb A, Dupont M, Curioni-Fontecedro A, Chiari R, Pantano F, Morabito A, Leonetti A, Friedlaender A, Addeo A, Zoratto F, De Tursi M, Cantini L, Roca E, Mountzios G, Della Gravara L, Kalvapudi S, Inno A, Bironzo P, Di Marco Barros R, O'Reilly D, Bell J, Karapanagiotou E, Monnet I, Baena J, Macerelli M, Majem M, Agustoni F, Cortinovis DL, Tonini G, Minuti G, Bennati C, Mezquita L, Gorría T, Servetto A, Beninato T, Lo Russo G, Rogado J, Moliner L, Biello F, Aboubakar Nana F, Dingemans AM, Aerts JGJV, Ferrara R, Torri V, Hejleh TA, Takada K, Naqash AR, Garassino M, … See abstract for full author list ➔ Cortellini A, et al. Among authors: karapanagiotou e. J Immunother Cancer. 2025 Feb 4;13(2):e010674. doi: 10.1136/jitc-2024-010674. J Immunother Cancer. 2025. PMID: 39904562 Free PMC article.
Therapy-induced toxicity of the lungs: an overview.
Charpidou AG, Gkiozos I, Tsimpoukis S, Apostolaki D, Dilana KD, Karapanagiotou EM, Syrigos KN. Charpidou AG, et al. Among authors: karapanagiotou em. Anticancer Res. 2009 Feb;29(2):631-9. Anticancer Res. 2009. PMID: 19331213 Free article. Review.
Head and neck cancer in the elderly: an overview on the treatment modalities.
Syrigos KN, Karachalios D, Karapanagiotou EM, Nutting CM, Manolopoulos L, Harrington KJ. Syrigos KN, et al. Among authors: karapanagiotou em. Cancer Treat Rev. 2009 May;35(3):237-45. doi: 10.1016/j.ctrv.2008.11.002. Epub 2008 Dec 18. Cancer Treat Rev. 2009. PMID: 19100689 Review.
49 results